Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.
Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.
复制标题
DOI:
10.1371/journal.pone.0253321
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Eckerle I
中科院分区:
文献类型:
--
作者:
Ngo Nsoga MT;Kronig I;Perez Rodriguez FJ;Sattonnet-Roche P;Da Silva D;Helbling J;Sacks JA;de Vos M;Boehm E;Gayet-Ageron A;Berger A;Jacquerioz-Bausch F;Chappuis F;Kaiser L;Schibler M;Renzoni A;Eckerle I
Antigen-detecting rapid diagnostic tests (Ag-RDTs) for the detection of SARS-CoV-2 offer new opportunities for testing in the context of the COVID-19 pandemic. Nasopharyngeal swabs (NPS) are the reference sample type, but oropharyngeal swabs (OPS) may be a more acceptable sample type in some patients. We conducted a prospective study in a single screening center to assess the diagnostic performance of the Panbio™ COVID-19 Ag Rapid Test (Abbott) on OPS compared with reverse-transcription quantitative PCR (RT-qPCR) using NPS during the second pandemic wave in Switzerland. 402 outpatients were enrolled in a COVID-19 screening center, of whom 168 (41.8%) had a positive RT-qPCR test. The oropharyngeal Ag-RDT clinical sensitivity compared to nasopharyngeal RT-qPCR was 81% (95%CI: 74.2–86.6). Two false positives were noted out of the 234 RT-qPCR negative individuals, which resulted in a clinical specificity of 99.1% (95%CI: 96.9–99.9) for the Ag-RDT. For cycle threshold values ≤ 26.7 (≥ 1E6 SARS-CoV-2 genomes copies/mL, a presumed cut-off for infectious virus), 96.3% sensitivity (95%CI: 90.7–99.0%) was obtained with the Ag-RDT using OPS. Based on our findings, the diagnostic performance of the Panbio™ Covid-19 RDT with OPS samples, if taken by a trained person and high requirements regarding quality of the specimen, meet the criteria required by the WHO for Ag-RDTs (sensitivity ≥80% and specificity ≥97%) in a high incidence setting in symptomatic individuals.
登录
查看更多内容
DOI:
10.1016/j.jinf.2021.02.014
发表时间:
2021-03
期刊:
The Journal of infection
影响因子:
--
作者:
Bulilete O;Lorente P;Leiva A;Carandell E;Oliver A;Rojo E;Pericas P;Llobera J;COVID-19 Primary Care Research Group
通讯作者:
COVID-19 Primary Care Research Group
影响因子:
15.1
作者:
Gremmels H;Winkel BMF;Schuurman R;Rosingh A;Rigter NAM;Rodriguez O;Ubijaan J;Wensing AMJ;Bonten MJM;Hofstra LM
通讯作者:
Hofstra LM
影响因子:
3.9
作者:
Wang, Huan;Liu, Qian;Xu, Shu-yun
通讯作者:
Xu, Shu-yun
影响因子:
4.8
作者:
Vetter P;Eberhardt CS;Meyer B;Martinez Murillo PA;Torriani G;Pigny F;Lemeille S;Cordey S;Laubscher F;Vu DL;Calame A;Schibler M;Jacquerioz F;Blanchard-Rohner G;Siegrist CA;Kaiser L;Didierlaurent AM;Eckerle I
通讯作者:
Eckerle I
影响因子:
3.7
作者:
Berger A;Nsoga MTN;Perez-Rodriguez FJ;Aad YA;Sattonnet-Roche P;Gayet-Ageron A;Jaksic C;Torriani G;Boehm E;Kronig I;Sacks JA;de Vos M;Bausch FJ;Chappuis F;Renzoni A;Kaiser L;Schibler M;Eckerle I
通讯作者:
Eckerle I